The lethal phenotype of cancer: the molecular basis of death due to malignancy.
about
Reviewing and reconsidering invasion assays in head and neck cancerDynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironmentA comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patientsDistinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3Disrupting the networks of cancerGlobal gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progressionMolecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.Redefining hormone resistance in prostate cancer.Applications of molecular MRI and optical imaging in cancer.Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering.Understanding cancer-induced cachexia: imaging the flame and its fuel.Maximum predictive power of the microarray-based models for clinical outcomes is limited by correlation between endpoint and gene expression profileThe relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer.Positive outcomes of oil palm phenolics on degenerative diseases in animal modelsPerspectives on tissue interactions in development and disease.Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations.Beyond the androgen receptor: new approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer MeetingSynergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases.Special considerations in prognostic research in cancer involving genetic polymorphismsNutritional interventions for cancer-induced cachexiaIGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia.Intravital microscopy in the mouse dorsal chamber model for the study of solid tumors.A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis.CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration.Organ microenvironment affects growth and metastasis of hepatocellular carcinoma via the TGF-β/Smad pathway in mice.Cell Competition Drives the Growth of Intestinal Adenomas in Drosophila.Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon CancerAnti-cytokine strategies for the treatment of cancer-related anorexia and cachexia.Tracing the origins of metastasis.Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-γ-mediated CD8(+) T cell cytotoxicity.Cancer cachexia, recent advances, and future directions.Ecology meets cancer biology: the cancer swamp promotes the lethal cancer phenotype.Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies.Transforming growth factor-β signaling induced during prostate cancer cell death and neuroendocrine differentiation is mediated by bone marrow stromal cells.Cancer tolerance, resistance, pathogenicity and virulence: deconstructing the disease state.Metastasis: an early event in cancer progression.Expression of Lysyl Oxidase Predictive of Distant Metastasis of Laryngeal Cancer.Metabolic signatures imaged in cancer-induced cachexia.Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers.A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy.
P2860
Q24289407-AC53DFB2-189C-4656-BBEE-94D1ABA766B5Q27025321-17DAAF2C-BBCA-4545-A9B3-4EF56BB70F8AQ28364947-9412CB42-E443-4FFA-8D32-8DD635588009Q28542391-179C3FD2-FD6B-49D8-81B7-BC4C77CC892BQ28656016-E874D177-684F-4AD1-BE3D-DEF7ABC8287EQ30157655-DA10315A-8F58-48C9-86CB-9CF0C85D5CFDQ33628125-8954CE10-462B-41AA-A3A3-207A6ED7D967Q33903836-8239CB5D-6804-4FF6-8470-95506EA430CCQ33986159-92E5AC26-AF79-467B-815E-0131505E9083Q34086276-D9322BE3-92C5-432C-AD02-8991A778F6D8Q34138093-B480D896-5331-4B8B-9F76-84D2CA48F22BQ34173294-1B037643-8AC5-4FD5-9350-2AA51B0E34E5Q34198587-8348A700-AC23-4ADE-A838-267278D149DEQ34264552-38FD259B-94D4-460E-B792-7978B7649589Q34330027-ED9A0674-D2DD-432C-8710-90AD92CFABF4Q34485047-36E66CF1-43F5-4461-921B-E4F72803A3C0Q34617627-FADFC695-B4A2-4D5C-857D-1BA2BD7039A2Q34763649-D40F74D5-A7F6-4F55-AE33-FDAA8C1EB203Q34775103-E6EAB807-726A-4622-8D06-1C530CDC0406Q35019743-7E74713F-19EB-4441-8EDA-98A5ABE5886EQ35053581-C3E0712C-F160-4118-B445-5AF76BBC7F7CQ35298115-8A9EA2E0-FFBD-47E7-B092-D92C7EEE0941Q35683556-C2AA135C-E81A-4AAD-BC29-E54145012B79Q35925135-E0BD0407-90C0-41C4-9046-22F63B29FFF5Q36472323-FFDC2531-DB1C-4BC2-AFCC-DC2AA88FD934Q36632955-DC690E93-9655-4E73-9240-FB2A9D410937Q36950475-40472D87-DBC7-415B-94AB-BD9A1423395BQ37769250-9AB511F0-00A9-4BA6-A171-01D2C9834D52Q37815132-C401D0E8-A592-4A9E-8556-5EDC7909BFB0Q38105994-4BE9DF0B-C453-437C-AE03-D2AA5C7A060FQ38393457-2AE77810-F28F-4464-928D-8F46CB71FABAQ38430999-A5093056-77B6-442D-89A7-637A274D636AQ38587843-68935667-8B18-483E-B8C5-80B4FF4C25D9Q38833670-4B7859BE-932F-4941-B1ED-D193C096ED90Q38888152-98C87E38-B0AB-489C-8AFC-4392E905E13AQ38968225-47162A03-A93A-40E0-B970-BDDBB0587D14Q39100384-24A06F3A-65FF-4477-BFAC-40BD7E8AB4B0Q39136440-B1EAE493-4D2C-4CE7-8042-FD40DB7624FAQ39154321-38C16D03-BDF0-443F-AAC3-9A1A9A4253B6Q39218137-3578BB98-1EEB-494D-955D-E51C228C5EEE
P2860
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@ast
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@en
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@nl
type
label
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@ast
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@en
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@nl
prefLabel
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@ast
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@en
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@nl
P2093
P1433
P1476
The lethal phenotype of cancer: the molecular basis of death due to malignancy.
@en
P2093
Arul M Chinnaiyan
Deborah A Bradley
Kenneth J Pienta
Robert D Loberg
Scott A Tomlins
P304
P356
10.3322/CANJCLIN.57.4.225
P407
P577
2007-07-01T00:00:00Z